Vertex Pharmaceuticals Inc. buy Scotiabank
Start price
14.11.25
/
50%
€377.95
Target price
14.11.26
-
Performance (%)
11.24%
Price
27.02.26
€420.45
Summary
This prediction is currently active. The BUY prediction by Scotiabank currently has a performance of 11.24%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.930% | 3.930% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Scotiabank for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Scotiabank for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€416.25
13.02.26
13.02.26
-
13.02.27
13.02.27
1.01%
27.02.26
27.02.26
